Tag Archives: Clinical trial

Pfizer to Launch Clinical Trial Network

By George Koroneos | Published: August 26, 2009
Image via Wikipedia Pfizer announced, last week, that it was partnering with technology firm Private Access to launch an online social network to help patients find clinical trials more easily. According to Pfizer, a top complaint from physicians is difficulty in matching patients with trials. “Finding volunteers has been a big issue for anyone conducting a clinical [...]
Posted in E-Media | Also tagged , , , , , | 5 Comments

Lilly Osteoporosis Drug Canned in Phase III Trials

By George Koroneos | Published: August 19, 2009
Image by go elsewhere… via Flickr Lilly, on Wednesday, announced that it would not seek regulatory approval for its osteoporosis treatment arzoxifene, because the drug failed to meet certain end points in Phase III clinical trials. The good news is that the drug was successful in meeting the primary end point of the trial, dubbed “GENERATIONS.” [...]
Posted in Strategy | Also tagged , , , , , | 1 Comment

NHLBI Cans Sildenafil Study After Reports of Severe Pain

By George Koroneos | Published: July 29, 2009
Image via Wikipedia The National Heart, Lung, and Blood Institute (NHLBI) announced, on Tuesday, that it was ending a clinical study involving Pfizer’s Revatio (sildenafil), a hypertension treatment and the active ingredient in Viagra, due to safety concerns. According to a lengthy release from the Institute, researchers realized that the patients in the study for the treatment [...]
Posted in News | Also tagged , , , , , , | Leave a comment

Chantix and Zyban Get Boxed Warnings

By George Koroneos | Published: July 1, 2009
Image via Wikipedia FDA announced yesterday afternoon that the smoking cessation drugs Chantix (varenicline) and Zyban (bupropion) must bear black box warnings for serious mental health symptoms, including changes in behavior, hostility, depression, and attempted suicide. In addition to being used in smoking cessation, buproprion is also marketed as an atypical antidepressant under the brand name Wellbutrin, [...]
Posted in Strategy | Also tagged , , , , , , | 6 Comments

Latest News from ASCO: Winners, Losers, and Also Rans

By Walter Armstrong | Published: June 3, 2009
Image via Wikipedia Due to pharma’s voluntary moratorium on doling out totefuls of freebies and all the lattes you can swallow, thousands of docs, researchers, and reporters had only their sleep-deprived selves to carry from data dump to data dump at this week’s American Society of Clinical Oncology (ASCO) annual confab in Orlando, Florida. Some 4,000 studies [...]
Posted in Events | Also tagged , , , , , | 2 Comments